Loading…
Murine chronotoxicity to pharmaceutical wastewater
The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks...
Saved in:
Published in: | Biological rhythm research 2014-03, Vol.45 (2), p.167-181 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853 |
container_end_page | 181 |
container_issue | 2 |
container_start_page | 167 |
container_title | Biological rhythm research |
container_volume | 45 |
creator | Dridi, Dorra Bchir, Fatma Zouiten, Amina Tahrani, Leyla Ben Mansour, Hedi |
description | The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p |
doi_str_mv | 10.1080/09291016.2013.787684 |
format | article |
fullrecord | <record><control><sourceid>fao_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_09291016_2013_787684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US201600079441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853</originalsourceid><addsrcrecordid>eNqFj11LwzAYhYMoOKf_QLB_oPNNmubjSmToFCZe6K7D2zRxla4Zacbcv7ejCt55dc7FeQ48hFxTmFFQcAuaaQpUzBjQYiaVFIqfkAmVnOecSn36p5-Ti77_hGEtgU0Ie9nFpnOZXcfQhRS-GtukQ5ZCtl1j3KB1u9RYbLM99sntMbl4Sc48tr27-skpWT0-vM-f8uXr4nl-v8wtU5DyWkgUpdJS1LWU1FWKObCO-rIaCkpRCJDCCu1LSjlCRSv0fqhQF5qpspgSPv7aGPo-Om-2sdlgPBgK5uhtfr3N0duM3gN2N2JN58NgsA-xrU3CQxuij9jZpjfFPw8344PHYPAjDsDqbRgIAJCac1p8A8sWaAc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Murine chronotoxicity to pharmaceutical wastewater</title><source>Taylor and Francis Science and Technology Collection</source><creator>Dridi, Dorra ; Bchir, Fatma ; Zouiten, Amina ; Tahrani, Leyla ; Ben Mansour, Hedi</creator><creatorcontrib>Dridi, Dorra ; Bchir, Fatma ; Zouiten, Amina ; Tahrani, Leyla ; Ben Mansour, Hedi</creatorcontrib><description>The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p < 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in −6.5% weight loss, whereas drug dosing at 9 HALO was + 1.2% (Ф = 19.42 HALO ± 1.25 h, p < 0.01). Only on the dark span, the proportion of dead mice was dosing-time-dependent (χ ² = 12.7; p < 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in the poorest (67%) survival rate; whereas, the best survival was noted in the rest span with 100%. Troughs of motor incoordination were located at the administration times of 9 and 21 HALO (16% of animals affected), whereas peaks were located at 5 and 17 HALO (38 and 55% of animals affected, respectively). A statistically significant ultradian component rhythm with a trial period = 12 h, was detected by cosinor (p < 0.009) the Ф = 17.00 HALO ± 1.70 h modulo 12 h. The toxicity was totally removed when the mice were treated by the bioremediated effluent. This indicates that Pseudomonas putida was able to completely detoxify the toxic pharmaceutical effluent. With regards to these data, the optimal tolerance to untreated pharmaceutical wastewater occurred in the light-rest span of mice.</description><identifier>ISSN: 1744-4179</identifier><identifier>ISSN: 0929-1016</identifier><identifier>EISSN: 1744-4179</identifier><identifier>DOI: 10.1080/09291016.2013.787684</identifier><language>eng</language><publisher>Taylor & Francis</publisher><subject>adverse effects ; ataxia (disorder) ; bioremediation ; body weight changes ; chronotoxicity ; circadian rhythm ; drugs ; mice ; pharmaceutical wastewater ; photoperiod ; Pseudomonas putida ; survival rate ; toxicity ; wastewater ; weight loss</subject><ispartof>Biological rhythm research, 2014-03, Vol.45 (2), p.167-181</ispartof><rights>2013 Taylor & Francis 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Dridi, Dorra</creatorcontrib><creatorcontrib>Bchir, Fatma</creatorcontrib><creatorcontrib>Zouiten, Amina</creatorcontrib><creatorcontrib>Tahrani, Leyla</creatorcontrib><creatorcontrib>Ben Mansour, Hedi</creatorcontrib><title>Murine chronotoxicity to pharmaceutical wastewater</title><title>Biological rhythm research</title><description>The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p < 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in −6.5% weight loss, whereas drug dosing at 9 HALO was + 1.2% (Ф = 19.42 HALO ± 1.25 h, p < 0.01). Only on the dark span, the proportion of dead mice was dosing-time-dependent (χ ² = 12.7; p < 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in the poorest (67%) survival rate; whereas, the best survival was noted in the rest span with 100%. Troughs of motor incoordination were located at the administration times of 9 and 21 HALO (16% of animals affected), whereas peaks were located at 5 and 17 HALO (38 and 55% of animals affected, respectively). A statistically significant ultradian component rhythm with a trial period = 12 h, was detected by cosinor (p < 0.009) the Ф = 17.00 HALO ± 1.70 h modulo 12 h. The toxicity was totally removed when the mice were treated by the bioremediated effluent. This indicates that Pseudomonas putida was able to completely detoxify the toxic pharmaceutical effluent. With regards to these data, the optimal tolerance to untreated pharmaceutical wastewater occurred in the light-rest span of mice.</description><subject>adverse effects</subject><subject>ataxia (disorder)</subject><subject>bioremediation</subject><subject>body weight changes</subject><subject>chronotoxicity</subject><subject>circadian rhythm</subject><subject>drugs</subject><subject>mice</subject><subject>pharmaceutical wastewater</subject><subject>photoperiod</subject><subject>Pseudomonas putida</subject><subject>survival rate</subject><subject>toxicity</subject><subject>wastewater</subject><subject>weight loss</subject><issn>1744-4179</issn><issn>0929-1016</issn><issn>1744-4179</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFj11LwzAYhYMoOKf_QLB_oPNNmubjSmToFCZe6K7D2zRxla4Zacbcv7ejCt55dc7FeQ48hFxTmFFQcAuaaQpUzBjQYiaVFIqfkAmVnOecSn36p5-Ti77_hGEtgU0Ie9nFpnOZXcfQhRS-GtukQ5ZCtl1j3KB1u9RYbLM99sntMbl4Sc48tr27-skpWT0-vM-f8uXr4nl-v8wtU5DyWkgUpdJS1LWU1FWKObCO-rIaCkpRCJDCCu1LSjlCRSv0fqhQF5qpspgSPv7aGPo-Om-2sdlgPBgK5uhtfr3N0duM3gN2N2JN58NgsA-xrU3CQxuij9jZpjfFPw8344PHYPAjDsDqbRgIAJCac1p8A8sWaAc</recordid><startdate>20140304</startdate><enddate>20140304</enddate><creator>Dridi, Dorra</creator><creator>Bchir, Fatma</creator><creator>Zouiten, Amina</creator><creator>Tahrani, Leyla</creator><creator>Ben Mansour, Hedi</creator><general>Taylor & Francis</general><scope>FBQ</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20140304</creationdate><title>Murine chronotoxicity to pharmaceutical wastewater</title><author>Dridi, Dorra ; Bchir, Fatma ; Zouiten, Amina ; Tahrani, Leyla ; Ben Mansour, Hedi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>adverse effects</topic><topic>ataxia (disorder)</topic><topic>bioremediation</topic><topic>body weight changes</topic><topic>chronotoxicity</topic><topic>circadian rhythm</topic><topic>drugs</topic><topic>mice</topic><topic>pharmaceutical wastewater</topic><topic>photoperiod</topic><topic>Pseudomonas putida</topic><topic>survival rate</topic><topic>toxicity</topic><topic>wastewater</topic><topic>weight loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dridi, Dorra</creatorcontrib><creatorcontrib>Bchir, Fatma</creatorcontrib><creatorcontrib>Zouiten, Amina</creatorcontrib><creatorcontrib>Tahrani, Leyla</creatorcontrib><creatorcontrib>Ben Mansour, Hedi</creatorcontrib><collection>AGRIS</collection><collection>CrossRef</collection><jtitle>Biological rhythm research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dridi, Dorra</au><au>Bchir, Fatma</au><au>Zouiten, Amina</au><au>Tahrani, Leyla</au><au>Ben Mansour, Hedi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Murine chronotoxicity to pharmaceutical wastewater</atitle><jtitle>Biological rhythm research</jtitle><date>2014-03-04</date><risdate>2014</risdate><volume>45</volume><issue>2</issue><spage>167</spage><epage>181</epage><pages>167-181</pages><issn>1744-4179</issn><issn>0929-1016</issn><eissn>1744-4179</eissn><abstract>The present study was undertaken to report the modeling of the dosing-time-dependent adverse effects of both untreated and biologically-treated pharmaceutical wastewater in mice. The mice were housed in a room controlled at 24 °C under a 12 h/12 h dark-light cycle (light 7:00–19:00 h) for two weeks before initiating the experiments and allowed free access to food and water. A single dose of pharmaceutical or bioremediated effluent was administrated intraperitoneally (10 mL/kg) to mice divided in six circadian stages [1, 5, 9, 13, 17, and 21 hours after light onset (HALO)]. The surviving treated mice exhibited a significant circadian variation in body weight loss (p < 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in −6.5% weight loss, whereas drug dosing at 9 HALO was + 1.2% (Ф = 19.42 HALO ± 1.25 h, p < 0.01). Only on the dark span, the proportion of dead mice was dosing-time-dependent (χ ² = 12.7; p < 0.001). Pharmaceutical wastewater dosing at 17 HALO resulted in the poorest (67%) survival rate; whereas, the best survival was noted in the rest span with 100%. Troughs of motor incoordination were located at the administration times of 9 and 21 HALO (16% of animals affected), whereas peaks were located at 5 and 17 HALO (38 and 55% of animals affected, respectively). A statistically significant ultradian component rhythm with a trial period = 12 h, was detected by cosinor (p < 0.009) the Ф = 17.00 HALO ± 1.70 h modulo 12 h. The toxicity was totally removed when the mice were treated by the bioremediated effluent. This indicates that Pseudomonas putida was able to completely detoxify the toxic pharmaceutical effluent. With regards to these data, the optimal tolerance to untreated pharmaceutical wastewater occurred in the light-rest span of mice.</abstract><pub>Taylor & Francis</pub><doi>10.1080/09291016.2013.787684</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1744-4179 |
ispartof | Biological rhythm research, 2014-03, Vol.45 (2), p.167-181 |
issn | 1744-4179 0929-1016 1744-4179 |
language | eng |
recordid | cdi_crossref_primary_10_1080_09291016_2013_787684 |
source | Taylor and Francis Science and Technology Collection |
subjects | adverse effects ataxia (disorder) bioremediation body weight changes chronotoxicity circadian rhythm drugs mice pharmaceutical wastewater photoperiod Pseudomonas putida survival rate toxicity wastewater weight loss |
title | Murine chronotoxicity to pharmaceutical wastewater |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A45%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-fao_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Murine%20chronotoxicity%20to%20pharmaceutical%20wastewater&rft.jtitle=Biological%20rhythm%20research&rft.au=Dridi,%20Dorra&rft.date=2014-03-04&rft.volume=45&rft.issue=2&rft.spage=167&rft.epage=181&rft.pages=167-181&rft.issn=1744-4179&rft.eissn=1744-4179&rft_id=info:doi/10.1080/09291016.2013.787684&rft_dat=%3Cfao_cross%3EUS201600079441%3C/fao_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c280t-d67a658976dd771eb82e0ce1f5b2e0a7636076c69f5114a0b1baff1140d392853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |